Brief: Elanix Biotechnologies initiates cash capital increase

Elanix Biotechnologies AG

30/01/2017 20:34

Jan 31 (Reuters) - Elanix Biotechnologies AG  ELNk.F : 
    * Said on Monday initiated a cash capital increase from 
authorized capital of up to 1,133,200 new shares with indirect 
shareholder subscription rights 
    * Said subscription ratio will be 5 to 1 
    * Subscription price was set at 4.20 euros ($4.49)per share 
 
Source text for Eikon:  ID:nEQ8RGlqW  
Further company coverage:  ELNk.F  
 
($1 = 0.9348 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))